IDSC ANNUAL CONFERENCE 2024


Speakers


Dr. Andrew Sibley Evaluation Programme Manager, Insight team at Health Innovation Wessex. The Insight team are a highly experienced group of researchers and evaluators from academia and NHS research departments. The team offers a range of support to innovators, private companies, and NHS partners in the Wessex (Hampshire and Dorset) region. It provides advice on evaluation methods, analytical methods, implementation frameworks, and outcome measures. The team also designs and delivers bespoke evaluations of innovation (i.e. new care pathways, digital technologies, new roles) and has completed 80 real-world evaluations of innovations in the region. Andrew undertook his PhD at the Centre for Innovation and Leadership, Faculty of Health Sciences, University of Southampton. He spent 13 years working on health services research studies in the university sector. He has worked in a range of nursing, medicine, and psychology departments in Southampton and London. As a programme manager at Health Innovation Wessex, Andrew works on a range of national and local evaluations and provides mixed methods and implementation science expertise to the Insight team.


Presentation title: How do we conduct real-world evaluations of new technologies and innovations within healthcare? Real-world evaluations (RWE) can support evidence developed from clinical trials on effectiveness. RWEs help service commissioners and innovators to understand the how, when, for whom, and why, an innovation has worked, or not, in real-world settings. Gathering this additional evidence helps clinicians to make better decisions about patient care and service leads make better decisions about how to run their services. This presentation will explore some of the common approaches to RWEs and discuss the recently completed RWE of PlasmaTyphoon+ at an NHS Decontamination Unit.


Gary Clarke Managing Director Gary has worked in the Healthcare and MedTech industries with 15 years’ experience in management and executive roles. In his current role Gary works as the CEO of IHSS Limited, specialists in the Medical Device Sterilisation field. Gary also acts as a Non-Executive Director for Audere Medical Services Ltd. Gary has had a varied career in commercial and operational roles where Gary’s expertise is in the areas of growth acceleration and transformation. He is passionate about the adoption of ethical, sustainable and digital business practices in health. Gary previously worked for the UK market leader in storage and shipping containers.


Dr. Gerald McDonnell, BSc PhD Vice President, Microbiological Quality & Sterility Assurance, Johnson & Johnson Dr. Gerald McDonnell is the Vice President for Microbiological Quality & Sterility Assurance at Johnson & Johnson. He manages a global team of experts in the areas of microbiology and contamination control including cleaning, disinfection, preservation, sterilisation, device processing and aseptic manufacturing. Prior to Johnson & Johnson, he worked with STERIS Corporation for 20 years in the USA and Europe in various scientific and clinical services roles. Dr. McDonnell has a B.Sc. (Hons.) in Medical Laboratory Sciences from the University of Ulster and a Ph.D. in Microbial Genetics from Trinity College Dublin. He has published over 180 publications and patents, including the books Block’s Disinfection, Sterilisation, and Preservation, A Practical Guide to Decontamination and Antisepsis, Disinfection, and Sterilisation. He is also the editor and referee for peer-reviewed journals and publications. He is a member of national and international working groups for standard and guideline development, including AAMI, ASTM, ISO and EN committees. He is a past convenor for CEN/TC102 WG8 (washer-disinfectors) and the Co-chair of the Sample Safety Assessment Advisory Team for the NASA/JPL MARS Mission. McDonnell is Board Director and Treasurer at AAMI (Association for the Advancement of Medical Instrumentation), as well as a member of the CSC, American Society of Microbiology, Parenteral Drug Association, and Hospital Infection Society.


W W W.I D S C. C O.U K 15


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40